Citius Pharmaceuticals, Inc. Increase Decrease In Operating Lease Liability
Citius Pharmaceuticals, Inc. (CTXR) reported Increase Decrease In Operating Lease Liability of -$46.32 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$41.20K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$21.48K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $16.37K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$68.38K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2025 was -$236.29K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2024 was -$218.38K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2023 was -$196.99K.
- Citius Pharmaceuticals, Inc. increase decrease in operating lease liability for fiscal 2022 was -$177.24K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$41.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$62.69K derived: sum of 2 quarters · filed 2026-08-14 | -$46.32K 10-Q · filed 2026-08-14 | -$114.69K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$21.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$5.11K 10-Q · filed 2026-05-15 | -$73.49K derived: sum of 3 quarters · filed 2026-05-15 | -$123.63K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $16.37K 10-Q · filed 2026-02-13 | -$52.01K derived: sum of 2 quarters · filed 2026-02-13 | -$102.15K derived: sum of 3 quarters · filed 2026-08-14 | -$161.62K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | -$68.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | -$118.52K derived: sum of 2 quarters · filed 2026-08-14 | -$177.99K derived: sum of 3 quarters · filed 2026-08-14 | -$236.29K 10-K · filed 2025-12-23 |
| 2025-06-30 | -$50.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-14 | -$109.61K derived: sum of 2 quarters · filed 2026-08-14 | -$167.91K 10-Q · filed 2026-08-14 | -$225.06K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$59.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-15 | -$117.77K 10-Q · filed 2026-05-15 | -$174.91K derived: sum of 3 quarters · filed 2026-05-15 | -$229.73K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$58.30K 10-Q · filed 2026-02-13 | -$115.44K derived: sum of 2 quarters · filed 2026-02-13 | -$170.26K derived: sum of 3 quarters · filed 2026-02-13 | -$224.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$57.15K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | -$111.97K derived: sum of 2 quarters · filed 2025-12-23 | -$165.70K derived: sum of 3 quarters · filed 2025-12-23 | -$218.38K 10-K · filed 2025-12-23 |
| 2024-06-30 | -$54.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$108.56K derived: sum of 2 quarters · filed 2025-08-12 | -$161.23K 10-Q · filed 2025-08-12 | -$212.87K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$53.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$106.41K 10-Q · filed 2025-05-14 | -$158.05K derived: sum of 3 quarters · filed 2025-05-14 | -$207.47K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$52.68K 10-Q · filed 2025-02-14 | -$104.31K derived: sum of 2 quarters · filed 2025-02-14 | -$153.73K derived: sum of 3 quarters · filed 2025-02-14 | -$202.18K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | -$51.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-27 | -$101.06K derived: sum of 2 quarters · filed 2024-12-27 | -$149.50K derived: sum of 3 quarters · filed 2024-12-27 | -$196.99K 10-K · filed 2024-12-27 |
| 2023-06-30 | -$49.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-12 | -$97.86K derived: sum of 2 quarters · filed 2024-08-12 | -$145.35K 10-Q · filed 2024-08-12 | -$191.90K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$48.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | -$95.93K 10-Q · filed 2024-05-14 | -$142.48K derived: sum of 3 quarters · filed 2024-05-14 | -$186.92K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$47.49K 10-Q · filed 2024-02-14 | -$94.04K derived: sum of 2 quarters · filed 2024-02-14 | -$138.47K derived: sum of 3 quarters · filed 2024-02-14 | -$182.03K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | -$46.55K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | -$90.98K derived: sum of 2 quarters · filed 2023-12-29 | -$134.54K derived: sum of 3 quarters · filed 2023-12-29 | -$177.24K 10-K · filed 2023-12-29 |
| 2022-06-30 | -$44.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | -$87.99K derived: sum of 2 quarters · filed 2023-08-14 | -$130.69K 10-Q · filed 2023-08-14 | -$172.54K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$43.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | -$86.25K 10-Q · filed 2023-05-12 | -$128.11K derived: sum of 3 quarters · filed 2023-05-12 | -$167.94K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$42.70K 10-Q · filed 2023-02-10 | -$84.55K derived: sum of 2 quarters · filed 2023-02-10 | -$124.38K derived: sum of 3 quarters · filed 2023-02-10 | -$163.43K derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | -$41.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | -$81.68K derived: sum of 2 quarters · filed 2022-12-22 | -$120.73K derived: sum of 3 quarters · filed 2022-12-22 | -$159.00K 10-K · filed 2022-12-22 |
| 2021-06-30 | -$39.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$78.87K derived: sum of 2 quarters · filed 2022-08-11 | -$117.14K 10-Q · filed 2022-08-11 | -$154.66K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$39.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$77.31K 10-Q · filed 2022-05-12 | -$114.83K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$38.27K 10-Q · filed 2022-02-10 | -$75.79K derived: sum of 2 quarters · filed 2022-02-10 | ||
| 2020-09-30 | -$37.52K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | -$123.25K 10-K · filed 2021-12-15 | ||
| 2020-06-30 | -$85.74K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |